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Introduction: Opsoclonus-myoclonus syndrome is a very rare neurological disorder associated with some viral
infections and exceptionally with the West Nile virus.
Case presentation: A 57-year-old Caucasian woman presented with fever, dizziness, balance difficulties, vomiting,
dancing eye, altered speech, tremor, generalized myoclonus and failure to rise or stand. Our objective is to describe
a patient with West Nile infection, which was identified both in her serum and cerebrospinal fluid and was
associated with encephalitis and opsoclonus-myoclonus-ataxia syndrome.
Conclusions: Opsoclonus-myoclonus-ataxia syndrome continued for 4 weeks after onset, when she died. There was
no evidence for any other etiology responsible for her opsoclonus-myoclonus syndrome. Her opsoclonus-myoclonus
syndrome appeared associated with West Nile encephalitis and had an unfavorable evolution despite treatment.
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Opsoclonus-myoclonus syndrome (OMS) also known as
the dancing eye syndrome is a very rare neurological dis-
order, affecting 1 in 10,000,000 people per year. In chil-
dren, OMS was associated with neuroblastoma; in adults
it may be associated with breast carcinoma or small-cell
lung carcinoma, uterus or ovarian cancers, rare gall blad-
der, pancreas and renal cell carcinoma. It can also be con-
sequent to toxic medication (amitriptyline, haloperidol,
diazepam), metabolic disorders [1], hydroelectrolytic dis-
orders, brain anoxia or autoimmune cause – Hashimoto's
encephalopathy [2], autoantibodies against neurons and
cerebellar Purkinje cells [3], celiac disease, and one of the
paraneoplastic syndromes. Although it is not considered
an infectious disease, it can be associated with some viral
infections, which may trigger the debut of OMS [4], such
as the Epstein–Barr virus, coxsackie B2, B3 virus, Saint
Louis encephalitis virus, human immunodeficiency virus
[1], hepatitis C infection [5], rubella, mumps [6], varicella-
zoster virus [7], and West Nile virus [8]. OMS was re-
ported as a poststreptococcal infection associated with
antibodies against a 56 kDa protein [9], in adolescents
following an infection with Mycoplasma pneumoniae* Correspondence: victoriabirlutiu@yahoo.com
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article, unless otherwise stated.[10], Rickettsia and as a manifestation of acute Borrelia
burgdorferi infection [11] and sometimes with vaccination.
The conventional therapies with corticosteroids, intraven-
ous immunoglobulin, plasmapheresis, adrenocorticotropin
hormone, antiepileptic drugs are associated with long-
term neurological morbidity; the combination of cyclo-
phosphamide and dexamethasone pulse therapy [12] or
rituximab administered in the refractory cases are pro-
mising [13,14]. The best treatment in adults is not very
clear. Steroids, baclofen, clonazepam, intravenous im-
munoglobulin, and immune-adsorption therapy are used
currently [15].
We report a case of opsoclonus-myoclonus syndrome
associated with West Nile encephalitis.Case presentation
Our patient was a 57-year-old Caucasian woman who
had an acute onset of dizziness 2 days prior to presenta-
tion to hospital. She began to have fever, 38.8°C, vomit-
ing, diarrhea, and sleepiness. Her past medical history
was dominated by larynx neoplasm (surgically eradicated
4 years before) and high blood pressure. She was not
on any medications. On admission she presented a
respiratory rate of 26 breaths/minute, arterial oxygenentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this





Ly 14.8%, Mxd 5.5%,
Hemoglobin 15g/dL
Hematocrit 42.4%
West Nile virus immunoglobulin M
2nd serum sample
Positive, increase in evolution
Lyme disease immunoglobulin M Negative
A cranial native computed tomography scan examination was performed and
showed infra and supratentorial focused ischemia lesions.
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sure 120/80mmHg, opsoclonus with rapid, involuntary,
multivectorial, conjugated fast eye movements persist-
ing during sleep, no modification of her visual field,
generalized myoclonus (brief, involuntary twitching of
muscles), and she was unable to perform the finger to
nose test; sleep disturbance, altered speech, mild neck
stiffness, positive Kernig's sign, abnormal plantar res-
ponses and diminished osteotendinous reflexes. Work
up included blood test and spinal fluid analysis, which
are summarized in Tables 1 and 2 (only pathological
results). Paraneoplastic antibodies anti-Hu, −Ri, −Yo
were negative.
The conclusions drawn from brain magnetic reson-
ance imaging were: cortical and cerebellum atrophy;
lacunary infarcts and bilateral infra-tentorial and over-
tentorial demyelinating lesions; and ethmoid sinusitis.
She was given intravenous dexamethasone, symptom-
atic treatment with clonazepam, cerebral depletion treat-
ment (such as administration of intravenous solutions
like mannitol), supportive therapy with intravenous fluid,
and antibiotics to prevent other types of bacterial infec-
tion. She had persistent OMS. After 2 weeks she presented
an acute retention of urine and 4 weeks after admission
she died. A postmortem examination did not reveal any
malignancy, systemic diseases or toxic etiology.
Discussion
The West Nile virus is a mosquito-borne zoonotic
arbovirus of the Flaviviridae family that is found in
temperate and tropical regions. It can cause a serious
neurological illness in less than 1% of infected people:
encephalitis, meningoencephalitis, acute flaccid paraly-
sis – poliomyelitis-like, Guillain–Barré syndrome and
optic neuritis. In Romania, in 1996, the West Nile was re-
sponsible for a high number of neuroinvasive diseases. In
recent years there has been a sporadic spread in this area,
and a few cases of meningitis or encephalitis have been
recorded annually. This is the first West Nile encephalitis
with OMC diagnosed in our country. OMC may occur
transiently in hyperglycemic coma but our patient pre-
sented hyperglycemia only on the first day after admission
and the West Nile infection was shown both in her serumTable 1 Cerebrospinal fluid studies
Cerebrospinal fluid Results




Gram smear No organism
Culture No growth
West Nile virus immunoglobulin M Positiveand cerebrospinal fluid (CSF) examination. Opsoclonus
can be associated with severe evolution to an immuno-
compromised host. Her CSF examination was associated
with a low CSF pleocytosis of 49 leukocytes/mm3 with
25% neutrophilic pleocytosis, more characteristic of West
Nile neuroinvasive disease than most other common
forms of viral encephalitis. CSF glucose was higher
because the blood glucose levels were higher.
Conclusions
In our patient the OMS appeared associated with West
Nile encephalitis and had an unfavorable evolution despite
treatment with corticosteroids. It is essential to combine
available treatments but the evolution is less satisfactory.
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